Functional and molecular biological evidence for a possible β3-adrenoceptor in the human detrusor muscle

British Journal of Pharmacology

Volumn 126, Issue 3, 1999, Pages 819-825

  Igawa, Yasuhiko ^a   Yamazaki, Yoshinobu ^b   Takeda, Hiroo ^b   Hayakawa, Kohichi ^b   Akahane, Masuo ^b   Ajisawa, Yukiyoshi ^b   Yoneyama, Takehisa ^a   Nishizawa, Osamu ^a   Andersson, Karl Erik ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adrenoceptor subtypes; Functional analysis; Human bladder; mRNA analysis

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; ISOPRENALINE; MESSENGER RNA; NORADRENALIN; PROCATEROL; SR 58894A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; DETRUSOR MUSCLE; DRUG POTENCY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MESSENGER RNA SYNTHESIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; DIOXOLES; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; ETHANOLAMINES; FEMALE; FORSKOLIN; GENE EXPRESSION; HUMANS; IMIDAZOLES; ISOPROTERENOL; MALE; MIDDLE AGED; MUSCLE RELAXATION; MUSCLE, SMOOTH; NOREPINEPHRINE; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032983692     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702358     Document Type: Article

References (33)

1. AIKAWA, J., FUKAZAWA, M., ISHIKAWA, M., MOROI, M., NAMIKI, A. & YAMAGUCHI, T. (1996). Vascular smooth muscle relaxation by α-adrenoceptor blocking action of dobutamine in isolated rabbit aorta. J. Cardiovasc. Pharmacol., 27, 33-36.
2. ANDERSON, G.F. & MARKS, B.H. (1984). Beta adrenoreceptors in the rabbit bladder detrusor muscle. J. Pharmacol. Exp. Ther., 228, 283-286.
3. ANDERSSON, K.-E. (1993). Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev., 45, 253-308.
4. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48-52.
5. 3-adrenoceptor mRNA in human tissues. Eur. J. Pharmacol., 289, 223-228.
6. 3 receptors. A promising antidiabetic and antibesity agent. J. Med. Chem., 35, 3081-3084.
7. 2- subtype. Br. J. Pharmacol., 110, 442-446.
8. 3-selective adrenoceptor antagonist, SR 59230A. Br. J. Pharmacol., 117, 1374-1376.
9. ELMÉR, M. (1974). Inhibitory β-adrenoceptors in the urinary bladder of the rat. Life Sci., 15, 273-280.
10. 3- adrenoceptor: the search for a physiological function. Trends Pharmacol. Sci., 15, 3-7.
11. 3-adrenergic receptor. Science, 245, 1118-1121.
12. GOEPEL, M., WITTMANN, A., RUBBEN, H. & MICHEL, M.C. (1997). Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol. Res., 25, 199-206.
13. 3- adrenoceptor-mediated relaxation of the human detrusor. Acta. Physiol. Scand., 164, 117-118.
14. KAUMANN, A.J. (1989). Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci., 10, 316-320.
15. KAUMANN, A.J. (1996). (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol., 117, 93-98.
16. KAUMANN, A.J. (1997). Four β-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol. Sci., 18, 70-76.
17. KOIKE, K., HORINOUCHI, T. & TAKAYANAGI, I. (1995). Possible mechanisms of β-adrenoceptor-mediated relaxation induced by noradrenaline in guinea pig taenia caecum. Eur. J. Pharmacol., 279, 159-163.
18. 3-adrenergic receptor mRNA in man. J. Clin. Invest., 91, 344-349.
19. LANDS, A.M., ARNOLD, A., MCAULIFF, J.P., LUDUENA, F.P. & BROWN JR, T.G. (1967a). Differentiation of receptor systems activated by sympathomimetic amines. Nature, 214, 597-598.
20. LANDS, A.M., LUDUENA, F.P. & BUZZO, H.J. (1967b). Differentiation of receptors responsive to isoproterenol. Life Sci., 6, 2241- 2249.
21. LANGIN, D., PORTILLO, M.P., SAULNIER-BLACHE, J.-S. & LAFONTAN, M. (1991). Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol., 199, 291-301.
22. LARSEN, J.-J. (1979). α- and β-adrenoceptors in the detrusor muscle and bladder base of the pig and β-adrenoceptors in the detrusor muscle of man. Br. J. Pharmacol., 65, 215-222.
23. LEVIN, R.M., RUGGIERI. M.R. & WEIN, A.J. (1988). Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. J. Urol., 139, 844-848.
24. LI, J.H., YASAY, G.D. & KAU, S.T. (1992). β-Adrenoceptor subtypes in the detrusor of guinea-pig urinary bladder. Pharmacology, 44, 13-18.
25. 3-selective antagonists, aryloxypropanolaminotetralins. Br. J. Pharmacol., 117, 435-442.
26. NERGÅRDH, A., BORÉUS, L.O. & NAGLO, A.-S. (1977). Characterization of the adrenergic beta-receptor in the urinary bladder of man and cat. Acta. Pharmacol. Toxicol., 40, 14-21.
27. ORIOWO, M.A., CHAPMAN, H., KIRKHAM, D.M., SENNITT, M.V., RUFFOLO JR, R.R. & CAWTHORNE, M.A. (1996). The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL37344. J. Pharmacol. Exp. Thera., 277, 22-27.
28. OZAKI, N., KAWAKITA, S. & TODA, N. (1982). Effects of dobutamine on isolated canine cerebral, coronary, mesenteric, and renal arteries. J. Cardiovasc. Pharmacol., 4, 456-461.
29. RUFFOLO, R.R. (1987). The pharmacology of dobutamine. Am. J. Med. Sci., 294, 244-248.
30. RUFFOLO JR, R.R., MESSICK, K. & HORNG, J.S. (1984). Interactions of the three inotropic agents, ASL-7022, dobutamine, and dopamine, with α- and β-adrenoceptors in vitro. Naynyn- Schmiedeberg's Arch. Pharmacol., 326, 317-326.
31. 3-adrenoceptors in rat detrusor smooth muscle. J. Urol., 159, 2197-2201.
32. TSO, J.Y., SUN, X.H., KAO, T.H., REECE, K.S. & WU, R. (1985). Isolation and characterization of rat and human glyceraldehyde- 3-phosphate dehydrogenase cDNAs: geomic complexity and molecular evolution of the gene. Nucleic Acids Res., 13, 2485- 2502.
33. YAMAZAKI, Y., TAKEDA, H., AKAHANE, M., IGAWA, Y., NISHIZAWA, O. & AJISAWA, Y. (1998). Species differences in the distribution of β-adrenoceptor subtypes in bladder smooth muscle. Br. J. Pharmacol., 124, 593-599.